- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03997890
Clinical Outcomes of Patients Bilaterally Implanted With the TECNIS® Symfony or TECNIS® Symfony Toric Extended Range of Vision IOL
In With increased patients' demand for a spectacle-free lifestyle and technological advancements, cataract surgery with multifocal intraocular lens (IOL) implantation has become an effective solution for correcting presbyopia in patients who want to maintain their full range of vision.
Conventional bifocal IOLs used either refractive or diffractive optics to split the light and create 2 principal focal points, thus providing functional vision at distance and near. This simultaneous imaging principle produces a sharp image that is overlaid by a secondary blurred out-of focus image, so these IOLs inherently produce a deterioration in contrast sensitivity and unwanted photic phenomena such as glare and halos. Additionally, studies reported insufficient intermediate vision with bifocal IOLs.
There is an increasing desire for spectacle independence at intermediate distance, especially due to the increased use of computers and smartphones. Trifocal IOLs were introduced to the market in 2010 and participants provide an additional, third focal point to improve intermediate vision without compromising distance and near vision. However, participants are still vulnerable to decreased contrast sensitivity and photic phenomena due to the IOL's mechanism of splitting the light into discrete focal points.
An extended depth of focus (EDOF) technology was recently introduced with the aim to improve intermediate vision while maintaining image contrast. The diffractive echelette design, embedded on its posterior optical surface, extends the range of vision and the achromatic technology reduces corneal chromatic aberrations to enhance retinal image quality and improve contrast sensitivity. The elongated focus allows imaging in a continuous range of vision without overlapping near and far images, and therefore theoretically would provide a more consistent distance and intermediate vision with less dysphotopsia.
The aim of this study was to investigate the clinical outcome of patients bilaterally implanted with either Tecnis Symfony or Tecnis Symfony toric extended range of vision IOLs (Johnson & Johnson Vision, Santa Ana, CA, USA) in terms of visual performance at different distances, spectacle independence, photic phenomena, and patient satisfaction.
Study Overview
Status
Conditions
Detailed Description
Enrollment period : 18 months after IRB approval Participants : Patients who had uncomplicated cataract surgery with binocular implantation of either Symfony (ZXR00) or Symfony toric (ZXT) IOLs.
Methods: The postoperative examinations were performed at 4-8 weeks, and 4-6 months postoperatively. Binocular corrected (CDVA) and uncorrected (UDVA) distance visual acuity was assessed at 4 m using a Snellen chart. Binocular uncorrected intermediate visual acuity (UIVA) at 70 cm and binocular uncorrected near visual acuity (UNVA) at 40 cm were assessed using the Rosenbaum near vision card.
A subjective questionnaire on spectacle use, photic phenomena, and satisfaction was administered to all patients. Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities. Non-directed and directed questions were used with regard to visual symptoms. Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe. Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied). Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family. Surgeons were also asked to rate their level of satisfaction on a scale from 0 to 10 in terms of the ease of manipulation and implantation of the IOL and the visual performance of the IOL.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Department of Ophthalmology, Yonsei Univeristy College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1. Age of 20 years or older
- 2. Cataract
Exclusion Criteria:
- 1. Amblyopia
- 2. Keratoconus
- 3. Previous corneal or refractive surgery
- 4. Chronic or recurrent uveitis
- 5. Acute ocular disease
- 6. Previous ocular surgeries
- 7. Glaucoma
- 8. Any ocular disease which could possible affect the postoperative visual acuity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Symfony group
The subjects who underwent cataract surgery with binocular implantation of either Symfony or Symfony toric IOLs
|
After creating an initial side port incision with a 15-degree blade, 3-step clear corneal incisions were made using a 2.5 mm disposable metal blade.
Sodium hyaluronate 1.0% (Healon; Abbott Medical Optics) was then injected into the anterior chamber.
A continuous curvilinear capsulorrhexis, measuring 5.5 mm in diameter, was generated using a 26 gauge bent needle.
After hydrodissection, phacoemulsification was done to remove nuclear fragments and aspiration of residual cortex.
In all eyes, a Symfony or Symfony toric IOL was implanted in the capsular bag using a disposable implantation system.
Irrigation and aspiration were performed to minimize ophthalmic viscoelastic surgical device retention at the end of surgery.
The main incision and side port were sealed with stromal hydration using a balanced salt solution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual outcome
Time Frame: preoperative 4-6 weeks
|
1. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.
|
preoperative 4-6 weeks
|
Visual outcome
Time Frame: preoperative 4-6 weeks
|
2. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.
|
preoperative 4-6 weeks
|
Visual outcome
Time Frame: preoperative 4-6 weeks
|
3. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.
|
preoperative 4-6 weeks
|
Visual outcome
Time Frame: preoperative 4-6 weeks
|
4. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.
|
preoperative 4-6 weeks
|
Visual outcome
Time Frame: preoperative 4-6 months
|
1. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.
|
preoperative 4-6 months
|
Visual outcome
Time Frame: preoperative 4-6 months
|
2. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.
|
preoperative 4-6 months
|
Visual outcome
Time Frame: preoperative 4-6 months
|
3. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.
|
preoperative 4-6 months
|
Visual outcome
Time Frame: preoperative 4-6 months
|
4. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.
|
preoperative 4-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spectacle use
Time Frame: Postoperative 4-6 weeks
|
Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities.
|
Postoperative 4-6 weeks
|
Spectacle use
Time Frame: Postoperative 4-6 months
|
Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities.
|
Postoperative 4-6 months
|
Photic phenomena
Time Frame: Postoperative 4-6 weeks
|
Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe.
|
Postoperative 4-6 weeks
|
Photic phenomena
Time Frame: Postoperative 4-6 months
|
Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe.
|
Postoperative 4-6 months
|
Patient Satisfaction
Time Frame: Postoperative 4-6 weeks
|
Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied).
Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family.
|
Postoperative 4-6 weeks
|
Patient Satisfaction
Time Frame: Postoperative 4-6 months
|
Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied).
Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family.
|
Postoperative 4-6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-2016-0029
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
National University Hospital, SingaporeSingapore General HospitalCompletedCataract Surgery | Stress Levels | Music Improving Outcomes in Cataract SurgerySingapore
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting